• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于量化健康人脑线粒体和突触功能的 3 种 PET 示踪剂的特征:F-BCPP-EF、C-SA-4503 和 C-UCB-J。

Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: F-BCPP-EF, C-SA-4503, and C-UCB-J.

机构信息

Invicro LLC, London, United Kingdom

Division of Brain Sciences, Imperial College London, London, United Kingdom.

出版信息

J Nucl Med. 2020 Jan;61(1):96-103. doi: 10.2967/jnumed.119.228080. Epub 2019 Jul 19.

DOI:10.2967/jnumed.119.228080
PMID:31324712
Abstract

Mitochondrial complex 1 is involved in maintaining brain bioenergetics; σ-1 receptor responds to neuronal stress; and synaptic vesicle protein 2A reflects synaptic integrity. Expression of each of these proteins is altered in neurodegenerative diseases. Here, we characterize the kinetic behavior of 3 PET radioligands-F-BCPP-EF, C-SA-4503, and C-UCB-J-for the measurement of mitochondrial complex 1, σ-1 receptor, and synaptic vesicle protein 2A, respectively, and determine appropriate analysis workflows for their application in future studies of the in vivo molecular pathology of these diseases. Twelve human subjects underwent dynamic PET scans with each radioligand, including associated arterial blood sampling. A range of kinetic models was investigated to identify an optimal kinetic analysis method for each radioligand and a suitable acquisition duration. All 3 radioligands readily entered the brain and yielded heterogeneous uptake consistent with the known distribution of the targets. The optimal models determined for the regional estimates of volume of distribution were multilinear analysis 1 (MA1) and the 2-tissue-compartment model for F-BCPP-EF, MA1 for C-SA-4503, and both MA1 and the 1-tissue-compartment model for C-UCB-J. Acquisition times of 70, 80, and 60 min for F-BCPP-EF, C-SA-4503, C-UCB-J, respectively, provided good estimates of regional volume of distribution values. An effect of age was observed on F-BCPP-EF and C-UCB-J signal in the caudate. These ligands can be assessed for their potential to stratify patients or monitor the progression of molecular neuropathology in neurodegenerative diseases.

摘要

线粒体复合物 1 参与维持大脑的生物能量;σ-1 受体对神经元应激做出反应;突触小泡蛋白 2A 反映了突触的完整性。这些蛋白质的表达在神经退行性疾病中发生改变。在这里,我们分别对 3 种 PET 放射性配体-F-BCPP-EF、C-SA-4503 和 C-UCB-J 的动力学行为进行了表征,以测量线粒体复合物 1、σ-1 受体和突触小泡蛋白 2A,并确定了适用于这些疾病体内分子病理学研究的合适分析工作流程。12 名人类受试者接受了每种放射性配体的动态 PET 扫描,包括相关的动脉血采样。研究了一系列动力学模型,以确定每种放射性配体的最佳动力学分析方法和合适的采集时间。所有 3 种放射性配体都很容易进入大脑,并产生与已知目标分布一致的异质摄取。确定的区域分布容积的最佳模型是单线性分析 1(MA1)和 2 组织室模型用于 F-BCPP-EF,MA1 用于 C-SA-4503,MA1 和 1 组织室模型都用于 C-UCB-J。对于 F-BCPP-EF、C-SA-4503 和 C-UCB-J,分别为 70、80 和 60 分钟的采集时间可提供区域分布容积值的良好估计。在尾状核中观察到年龄对 F-BCPP-EF 和 C-UCB-J 信号的影响。这些配体可以评估它们在神经退行性疾病中分层患者或监测分子神经病理学进展的潜力。

相似文献

1
Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: F-BCPP-EF, C-SA-4503, and C-UCB-J.用于量化健康人脑线粒体和突触功能的 3 种 PET 示踪剂的特征:F-BCPP-EF、C-SA-4503 和 C-UCB-J。
J Nucl Med. 2020 Jan;61(1):96-103. doi: 10.2967/jnumed.119.228080. Epub 2019 Jul 19.
2
Test-retest variability and reference region-based quantification of F-BCPP-EF for imaging mitochondrial complex I in the human brain.用于在人脑成像中检测线粒体复合物 I 的 F-BCPP-EF 的重测变异性和基于参考区域的定量。
J Cereb Blood Flow Metab. 2021 Apr;41(4):771-779. doi: 10.1177/0271678X20928149. Epub 2020 Jun 5.
3
Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.11C-UCB-J作为用于脑部突触囊泡糖蛋白2A成像的正电子发射断层显像(PET)示踪剂的合成及临床前评估
J Nucl Med. 2016 May;57(5):777-84. doi: 10.2967/jnumed.115.168179. Epub 2016 Feb 4.
4
Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers.氟-18 标记突触小泡蛋白 2A(SV2A)正电子发射断层扫描(PET)示踪剂的研发及其在体内的临床前影像学研究。
Mol Imaging Biol. 2019 Jun;21(3):509-518. doi: 10.1007/s11307-018-1260-5.
5
Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle 2A in Early Drug-Naive Parkinson's Disease.早期未经药物治疗的帕金森病中的线粒体复合物 1、西格玛 1 和突触小泡 2A。
Mov Disord. 2020 Aug;35(8):1416-1427. doi: 10.1002/mds.28064. Epub 2020 Apr 29.
6
First-in-Human Evaluation of F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A.人源化 F-SynVesT-1 的首次临床评估,一种用于突触囊泡糖蛋白 2A 的 PET 成像放射性配体。
J Nucl Med. 2021 Apr;62(4):561-567. doi: 10.2967/jnumed.120.249144. Epub 2020 Aug 28.
7
In vivo imaging of synaptic density with [C]UCB-J PET in two mouse models of neurodegenerative disease.使用 [C]UCB-J PET 在两种神经退行性疾病小鼠模型中进行突触密度的体内成像。
Neuroimage. 2021 Oct 1;239:118302. doi: 10.1016/j.neuroimage.2021.118302. Epub 2021 Jun 23.
8
Evaluation of 18F-BCPP-EF for mitochondrial complex 1 imaging in the brain of conscious monkeys using PET.使用正电子发射断层扫描(PET)评估18F-BCPP-EF在清醒猴子大脑中线粒体复合物1成像中的应用。
Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):755-63. doi: 10.1007/s00259-013-2628-z. Epub 2013 Nov 21.
9
Kinetic evaluation and test-retest reproducibility of [C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans.新型正电子发射断层扫描显像剂[C]UCB-J 用于突触囊泡糖蛋白 2A 的动力学评估及其在人体中的重测信度研究。
J Cereb Blood Flow Metab. 2018 Nov;38(11):2041-2052. doi: 10.1177/0271678X17724947. Epub 2017 Aug 9.
10
Development of novel PET probes, [18F]BCPP-EF, [18F]BCPP-BF, and [11C]BCPP-EM for mitochondrial complex 1 imaging in the living brain.用于活体脑线粒体复合物I成像的新型正电子发射断层显像(PET)探针[18F]BCPP-EF、[18F]BCPP-BF和[11C]BCPP-EM的研发。
J Labelled Comp Radiopharm. 2013 Sep;56(11):553-61. doi: 10.1002/jlcr.3056. Epub 2013 Jul 30.

引用本文的文献

1
Evaluation of Mitochondrial Complex 1 Density with [F]BCPP-EF in a Murine Model and Individuals with Friedreich Ataxia.在小鼠模型和弗里德赖希共济失调患者中用[F]BCPP-EF评估线粒体复合物I密度
J Nucl Med. 2025 Sep 2;66(9):1434-1439. doi: 10.2967/jnumed.124.268698.
2
Plasma vesicle-associated membrane protein 2 and glial fibrillary acidic protein associate with synaptic density in older adults without dementia.血浆囊泡相关膜蛋白2和胶质纤维酸性蛋白与无痴呆症老年人的突触密度相关。
Brain Commun. 2025 May 27;7(4):fcaf207. doi: 10.1093/braincomms/fcaf207. eCollection 2025.
3
Synaptic Density in Multiple Sclerosis: An In Vivo Study Using [C]UCB-J-PET Imaging.
多发性硬化症中的突触密度:一项使用[C]UCB-J正电子发射断层扫描成像的体内研究。
Neurol Neuroimmunol Neuroinflamm. 2025 Sep;12(5):e200435. doi: 10.1212/NXI.0000000000200435. Epub 2025 Jul 3.
4
Assessment of the relationship between synaptic density and metabotropic glutamate receptors in early Alzheimer's disease: a multi-tracer PET study.早期阿尔茨海默病中突触密度与代谢型谷氨酸受体之间关系的评估:一项多示踪剂PET研究。
Alzheimers Res Ther. 2025 May 6;17(1):98. doi: 10.1186/s13195-025-01739-1.
5
Advances in synaptic PET imaging and intervention with synapse-targeted small-molecular drugs for dementia diagnosis and therapy.用于痴呆症诊断和治疗的突触PET成像及突触靶向小分子药物干预的进展。
Fundam Res. 2024 Apr 21;5(1):63-71. doi: 10.1016/j.fmre.2024.04.013. eCollection 2025 Jan.
6
The relationship between cortical synaptic terminal density marker SV2A and glutamate early in the course of schizophrenia: a multimodal PET and MRS imaging study.精神分裂症病程早期皮质突触终末密度标志物SV2A与谷氨酸之间的关系:一项多模态PET和MRS成像研究
Transl Psychiatry. 2025 Mar 1;15(1):70. doi: 10.1038/s41398-025-03269-8.
7
Identifying Biomarkers for Remyelination and Recovery in Multiple Sclerosis: A Measure of Progress.识别多发性硬化症中再髓鞘化和恢复的生物标志物:进展的衡量标准。
Biomedicines. 2025 Feb 4;13(2):357. doi: 10.3390/biomedicines13020357.
8
The relationship between SV2A levels, neural activity, and cognitive function in healthy humans: A [11C]UCB-J PET and fMRI study.健康人群中突触囊泡蛋白2A(SV2A)水平、神经活动与认知功能之间的关系:一项[11C]UCB-J正电子发射断层扫描(PET)和功能磁共振成像(fMRI)研究。
Imaging Neurosci (Camb). 2024 Jun 10;2:1-16. doi: 10.1162/imag_a_00190. eCollection 2024 Jun 1.
9
Characterization of a novel PET radioligand for mitochondrial complex I in nonhuman primate.一种用于非人类灵长类动物线粒体复合体I的新型正电子发射断层显像(PET)放射性配体的表征
Nucl Med Biol. 2025 Mar-Apr;142-143:108993. doi: 10.1016/j.nucmedbio.2025.108993. Epub 2025 Jan 10.
10
Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design.探索裸盖菇素辅助心理治疗饮食失调的神经生物学相关性:潜在方法综述及其对迷幻剂研究设计的启示
J Eat Disord. 2024 Dec 27;12(1):214. doi: 10.1186/s40337-024-01185-8.